G01N 2333/5758
Gastrin releasing peptide
G01N2333/5758 (Gastrin releasing peptide) appears on 11 US grants and 14 published applications in this corpus.
Search patents in G01N- Granted patents
- 11
- Published applications
- 14
- Assignees
- 17
- Inventors
- 27
- Latest grant
- 6 Aug 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 1 | 3 |
| 2010 | 0 | 2 |
| 2011 | 2 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Prophylaxis of colorectal and gastrointestinal cancer6 Aug 2019US 10,370,444 B2Centre National de la Recherche Scientifique (CNRS)
- Immunoassay method for pro-gastrin-releasing peptide4 Sep 2018US 10,067,124 B2Abbott Japan Co., Ltd.
- Immunoassay method for pro-gastrin-releasing peptide4 Oct 2016US 9,459,248 B2Abbott Japan Co., Ltd.
- Antibody directed against pro-gastrin releasing peptide, and use thereof17 Dec 2013US 8,609,424 B2Advanced Life Science Institute, Inc.
- Antibody directed against gastrin-releasing peptide precursor and use thereof19 Apr 2011US 7,927,814 B2Advanced Life Science Institute, Inc.
- Prophylaxis of colorectal and gastrointestinal cancer17 Aug 2017US 2017/0233469 A1Centre National de la Recherche Scientifique (CNRS)
- Immunoassay method for pro-gastrin-releasing peptide30 Mar 2017US 2017/0089889 A1Abbott Japan Co., Ltd.
- Prophylaxis of colorectal and gastrointestinal cancer12 Mar 2015US 2015/0071912 A1Centre National de la Recherche Scientifique (CNRS)
- Immunoassay method for pro-gastrin-releasing peptide25 Sep 2014US 2014/0287532 A1Abbott Japan Co., Ltd.
- Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide10 Apr 2014US 2014/0100163 A1The United States of America, as represented by the Secretary, Department of Health and Human Serv
Most cited
By later US patents
- Peptide library formats and methods relating thereto15US 5,601,992 ABunsen Rush Laboratories, Inc. · 1997
- Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides14US 7,915,002 B2B.R.A.H.M.S GmbH · 2011
- Prophylaxis of colorectal and gastrointestinal cancer3US 10,370,444 B2Centre National de la Recherche Scientifique (CNRS) · 2019
- Antibody directed against gastrin-releasing peptide precursor and use thereof2US 7,927,814 B2Advanced Life Science Institute, Inc. · 2011
- Solubilization and purification of the active gastrin releasing peptide receptor1US 5,215,963 ABerlex Laboratories, Inc. · 1993